ClinicalTrials.govpublic full text
Intermediate Size Expanded Access Protocol for the Treatment of Post-COVID-19 Syndrome
post covid-19 syndrome, long haul covid-19, covid-19, sars-cov-2, long haulers, stem cells, mscs, mesenchymal stem cells, covid, post covid, expanded access
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 868610
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.